The Journal of Clinical Endocrinology and Metabolism
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
View on PubMed
VentraSciencesVentraSciencesTrending
A research blend of CJC-1295 (no DAC) 5mg + Ipamorelin 5mg. For laboratory research use only.
Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.
Technical specifications
This research-grade blend combines CJC-1295 without DAC (GHRH analog) with Ipamorelin (selective GHRP) for synergistic growth-hormone-release research.
Research applications: Standard combination protocol in growth-hormone axis research.
Peer-reviewed research
References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.
This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.
This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.
By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.
Exclusive updates and restock alerts, straight to your inbox.
